Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2 by Liniger, Matthias et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chicken cells sense influenza A virus infection through MDA5
and CARDIF signaling involving LGP2
Citation for published version:
Liniger, M, Summerfield, A, Zimmer, G, McCullough, KC & Ruggli, N 2012, 'Chicken cells sense influenza A
virus infection through MDA5 and CARDIF signaling involving LGP2' Journal of Virology, vol. 86, no. 2, pp.
705-17. DOI: 10.1128/JVI.00742-11
Digital Object Identifier (DOI):
10.1128/JVI.00742-11
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Virology
Publisher Rights Statement:
Freely available in PMC.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Chicken Cells Sense Influenza A Virus Infection through MDA5 and
CARDIF Signaling Involving LGP2
Matthias Liniger, Artur Summerﬁeld, Gert Zimmer, Kenneth C. McCullough, and Nicolas Ruggli
Institute of Virology and Immunoprophylaxis (IVI), Mittelhäusern, Switzerland
Avian influenza viruses (AIV) raiseworldwide veterinary andpublic health concerns due to their potential for zoonotic transmission.
While infectionwith highly pathogenic AIV results in highmortality in chickens, this is not necessarily the case inwild birds and
ducks. It is known that innate immune factors can contribute to the outcomeof infection. In this context, retinoic acid-inducible gene I
(RIG-I) is themain cytosolic pattern recognition receptor known for detecting influenzaA virus infection inmammalian cells. Chick-
ens, unlike ducks, lackRIG-I, yet chicken cells do produce type I interferon (IFN) in response toAIV infection. Consequently, we
sought to identify the cytosolic recognition elements in chicken cells. ChickenmRNAencoding the putative chicken analogs of
CARDIF andLGP2 (chCARDIF and chLGP2, respectively)were identified.HT7-tagged chCARDIFwas observed to associatewithmi-
tochondria in chickenDF-1 fibroblasts. The exogenous expression of chCARDIF, aswell as of the caspase activation and recruitment
domains (CARDs) of the chickenmelanomadifferentiation-associated protein 5 (chMDA5), strongly activated the chicken IFN-
(chIFN-) promoter. The silencing of chMDA5, chCARDIF, and chIRF3 reduced chIFN- levels induced byAIV, indicating their in-
volvement inAIV sensing. Aswithmammalian cells, chLGP2had opposing effects.While overexpression decreased the activation of
the chIFN-promoter, the silencing of endogenous chLGP2 reduced chIFN- induced byAIV.Wefinally demonstrate that the
chMDA5 signaling pathway is inhibited by the viral nonstructural protein 1. In conclusion, chicken cells, includingDF-1 fibroblasts
andHD-11macrophage-like cells, employ chMDA5 for sensingAIV.
Avian influenza virus (AIV) represents a continuous threat fordomestic poultry and humans (7, 34). Both highly pathogenic
(HP) and low-pathogenicity (LP) AIV can cause disease in hu-
mans (30). InfectionswithHPAIV cause highmorbidity andmor-
tality in gallinaceous poultry but typically do not do so in wild
waterfowl (36).Ducks that are infected experimentallywithH5N1
do not necessarily develop disease, although virus spreading and
shedding can be observed. Knowledge of the innate immune rec-
ognition of AIV is crucial to understanding the viral pathogenesis
in birds. The recognition of viruses by host cells is mediated by
pathogen recognition receptors (PRR) sensing virus-specific
pathogen-associated molecular patterns (PAMPs), typically viral
nucleic acids. PRR activation results in type I interferon (IFN)
induction, cytokine secretion, and the activation of antigen-
presenting cells promoting adaptive immune responses (51, 53).
PRRs are classified in two main categories: the Toll-like receptors
and the retinoic acid-inducible gene I (RIG-I)-like receptors
(RLR). RLR are ubiquitously expressed in the cytoplasm (59) and
comprise the three helicases RIG-I, melanoma differentiation-
associated protein 5 (MDA5), and laboratory of genetics and
physiology 2 (LGP2). RIG-I and MDA5 contain two N-terminal
caspase activation and recruitment (CARD) domains, a
DEX(D/H) box RNA helicase domain, and a C-terminal regula-
tory or repressor domain (CTD) (9). LGP2 is devoid of CARD
domains and therefore lacks signaling capacity (49). It is a positive
regulator of the RLR-specific antiviral responses (42, 54). The
overexpression of LGP2 can, however, interfere with RLR signal-
ing (40). The RIG-I CTD is involved in viral RNAbinding, and the
CARDs are required for the interaction with the CARDdomain of
the mitochondrial adaptor molecule CARDIF, also known as
MAVS, IPS-1, or VISA (25, 31, 46, 50, 52, 57). The activation of
CARDIF and of the downstream signaling cascade results in the
activation of the transcription factors NF-B and IRF3 and in the
secretion of proinflammatory cytokines and type I IFNs (58).
RIG-I was first reported to recognize double-stranded RNA
(dsRNA) structures and uncapped 5=-triphosphate (5=-ppp)
single-stranded RNA (ssRNA) generated by viral RNA poly-
merases (18, 38, 60). Later it was found that 5=-ppp recognition by
RIG-I requires short blunt 5=-ppp dsRNA, which are contained in
panhandle structures of negative-strand RNA viruses (43, 44).
MDA5 can be activated by dsRNA, including the synthetic dsRNA
analogue p(I:C) (23, 26). Studies conducted with RIG-I-deficient
andMDA5-deficient mice demonstrate the essential role of RIG-I
for type I IFN induction in response to various negative-strand
RNA viruses, while MDA5 senses essentially positive-strand RNA
viruses, in particular members of the Picornaviridae and Flaviviri-
dae families (11, 13, 24, 29).However,MDA5 also can be triggered
by certain negative-strand RNA viruses, such as members of the
Paramyxoviridae family (13) and by AIV (56). Although the RLR
pathway generally is conserved among vertebrates, the RIG-I gene
could not be identified in chicken (2, 62). Barber and coworkers
characterized the duck RIG-I function and suggested that the lack
of RIG-I observed in chicken results in a deficiency of the antiviral
innate immune response induced by this pathway, possibly ex-
plaining the increased susceptibility of chickens compared to that
of ducks to AIV (2). Very recently, however, the chicken MDA5
(chMDA5) was identified to mediate type I IFN responses in
chicken cells stimulated with synthetic dsRNA (22). This suggests
that chickens sense AIVwithMDA5. The present study is aimed at
characterizing the molecular mechanisms by which chicken DF-1
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fibroblast and HD-11 macrophage-like cells sense AIV infections,
leading to type I IFN secretion. We show that chMDA5 acts as the
chicken PRR responsible for sensing influenza A virus infections
in the two chicken cell lines. In addition, we identified chCARDIF,
which is essential to mediate chMDA5-dependent type I IFN in-
duction. We also identified chLGP2 and show that it functions as
a positive regulator of chMDA5 signaling, similarly to LGP2 in the
mammalian RLR pathway. Importantly, the NS1 protein of AIV
inhibited the chMDA5 signaling, as is the case for RIG-I signaling
in mammalian cells. These data highlight the relevance of the
chMDA5 helicase pathway in sensing AIV.
MATERIALS AND METHODS
Cells. DF-1 and HEK293T cells (both from ATCC, Manassas, VA) were
propagated in Dulbecco’s minimal essential medium (DMEM) plus
GlutaMAX-I (Invitrogen) supplemented with 10% heat-inactivated fetal
bovine serum (FBS) (Biowest). HD-11 (4) and CEC-32 (45) cells were
cultivated in DMEM plus GlutaMAX-I supplemented with 2% chicken
serum (Invitrogen) and 8% heat-inactivated FBS. CEC-32 cells carry a
luciferase gene under the control of the IFN-responsive chicken Mx pro-
moter and were used to quantify bioactive chicken type I IFN. All avian
cells were incubated at 39°C. Madin-Darby canine kidney (MDCK) cells
were propagated inMEMwith 10% FBS, nonessential amino acids, and 1
mM sodium pyruvate (all from Invitrogen). The stable cell line MDCK-
NS1-GFP, expressing influenzaANS1 (kindly provided byAdolfoGarcia-
Sastre, Mount Sinai School of Medicine, New York, NY) was propagated
in MDCK medium with 0.1 mg/ml hygromycin B (Calbiochem, Basel,
Switzerland).
Viruses. A set of eight pHW2000-based plasmids encompassing the
gene segments of the LPAIV A/duck/Hokkaido/Vac-1/04 (H5N1) (Vac-
1/04) (48) virus was kindly provided by Yoshida Sakoda (Hokkaido Uni-
versity, Sapporo, Japan) with the permission of Robert G. Webster (De-
partment of Infectious Diseases, St. Jude Children’s Research Hospital,
Memphis, TN). The rescue of viruses from transfected cocultures of
HEK293T and MDCK cells was performed as described previously (16)
using TransIT-293 (Mirus, Madison, WI). The viruses were amplified in
MDCK cells in the presence of 1 g/ml tosylsulfonyl phenylalanyl chlo-
romethyl ketone (TPCK)-trypsin (Worthington Biochemical, Lakewood,
NJ), and the titers were determined as 50% tissue culture infectious doses
(TCID50/ml) by monitoring the cytopathic effect (CPE) of endpoint di-
lutions on the same cells. Vac-1/04 virus devoid of the NS1 gene (Vac-
NS1) was rescued by transfecting cocultures of HEK293T and MDCK-
NS1-GFP cells with the plasmid pHW-2000-NS-V-NS1 (see below) and
the seven parent Vac-1/04 plasmids. Vac-NS1 virus stocks were pro-
duced and titrated on MDCK-NS1-GFP cells. All experiments with AIV
were performed under biosafety level 3 (BSL-3) conditions. Recombinant
vesicular stomatitis virus (VSV) replicons devoid of the G surface glyco-
protein were packaged into infectious particles using a BHK cell line ex-
pressing G glycoprotein. The VSV*MQG replicon expresses a mutant
matrix protein which cannot antagonize the induction of type I IFN (17).
The VSV*G(Luc) replicon expressing firefly luciferase was constructed
as described elsewhere (3).
Site-directed mutagenesis of NS1. The position of the reported
A149V substitution inNS1 (28) corresponds to position 144 in theNS1 of
A/chicken/Yamaguchi/7/2004 (H5N1) virus (19). To insert the A144V
mutation, the 5=-phosphorylated oligonucleotides Y-NS1mutAV-R and
Y-NS1mutAV-F (Table 1 lists all oligonucleotides used for plasmid con-
structions) were used for PCRwith the pHW2000-derived plasmid carry-
ing the Yamaguchi-7/04 NS segment as the template. The religated DNA
fragment resulted in plasmid pHW-Y-NS1A144V. The coding regions of
Yamaguchi-7/04 NS1 and NS1-A144V were amplified with NS1-Y-L and
NS1-VY-R and cloned with BamHI and EcoRI into pcDNA6-V5-His B
(Invitrogen). The Vac-1/04 NS1 and NS1-A149V expression plasmids
were cloned accordingly. For the NS1-deficient construct, the pHW2000-
derived plasmid carrying the Vac-1/04 NS segment served as the template
in a PCR using the 5=-phosphorylated oligonucleotides dNS1-V-R and
dNS1-V-L. The product was ligated to obtain plasmid pHW-2000-NS-V-
NS1.
SDS-PAGE and Western blotting. Cells were lysed in a hypotonic
buffer containing 20mMmorpholinepropanesulfonic acid, 10mMNaCl,
1.5mMMgCl2, 1%TritonX-100 (pH6.5), and protease inhibitor cocktail
(Sigma). Proteins were separated by SDS-PAGE under reducing condi-
tions and analyzed by Western blotting (41) using anti-V5 (Invitrogen),
anti-HaloTag (Promega), or anti--actin (C4) antibodies (Santa Cruz)
and IRDye-labeled secondary antibodies (Li-Cor Biosciences). The sig-
nals were acquired and quantified using the Odyssey infrared imaging
system (Li-Cor Biosciences).
Design of chicken IFN- and Mx promoter reporter plasmids. The
chicken IFN- promoter (GenBank accession no. Y14969.1) (47) andMx
promoter (GenBank accession no. EF487534.1) were amplified from
White Leghorn chicken genomic DNA by PCR using the oligonucleotides
ch-P-IFNb-L and ch-P-IFNb-R or ch-P-Mx-L and ch-P-Mx-R, respec-
tively. The fragments were cloned with SmaI and HindII to replace the
mouse Mx promoter in pGL3-Mx1P-FF-Luc (a kind gift of Georg Kochs,
Department of Virology, University of Freiburg, Germany) (20), resulting
in pGL3-P-chIFN--luc and pGL3-P-chMx-luc.
Preparation and enzymatic treatments of RNA stimuli. Polyinos-
inic-poly(C) [p(I:C)] sodiumwas purchased fromSigma. The production
of in vitro-transcribed RNA (IVT-RNA) was performed as described pre-
viously (18), with minor modifications. HindIII-linearized pBluescriptII
SK served as the template using theMEGAscript T7 kit (Ambion). After
DNase I treatment, the IVT-RNA was purified using Mini-Quick Spin
Oligo Columns (Roche). Corresponding synthetic ssRNA (51 nucleo-
tides) devoid of 5=-ppp structures was obtained from Microsynth (Bal-
gach, Switzerland). For dephosphorylation, 15 g of RNA was treated
with 200 U of calf intestinal alkaline phosphatase (CIP; Promega). RNA
digestions (15 g) were performed using an RNase cocktail (Ambion)
in 100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 mM dithiothre-
itol (pH 7.9) for 2 h at 37°C. All reaction mixtures were heat inacti-
vated at 65°C for 15 min and purified twice using Mini-Quick Spin
Oligo columns (Roche).
Transient promoter reporter assays in chicken DF-1 cells. To deter-
mine chicken IFN- and Mx promoter activities, DF-1 cells grown in
96-well plate format at 2  104 to 4  104 cells/well were cotransfected
with 25 to 50 ng/well of pGL3-P-chIFN--luc or pGL3-P-chMx-luc and
0.1 ng/well of a plasmid constitutively expressing Renilla luciferase
(phRL-SV40; Promega) using Fugene HD (Roche). HEK293T cells were
transfected with plasmid p125Luc (61) and phRL-SV40. Cells were lysed
using 20 l of 1 passive lysis buffer (Promega), and samples were as-
sayed for firefly and Renilla luciferase activity using the dual-luciferase
reporter assay system (Promega) and a Centro LB 960 luminometer
(Berthold Technologies).
Chicken type I IFN bioassay. Bioactive type I chicken interferon
(IFN) was measured using CEC-32 reporter cells (kindly provided by
Peter Staeheli) adapted to 96-well plate format (33, 45). To avoid inter-
ference with the bioassay, p(I:C) and IVT-RNAwere removed fromDF-1
or HD-11 cells after 3 h. Virus interference was avoided by the heat inac-
tivation of the samples at 65°C for 30 min, which did not influence type I
chIFN bioactivity.
Cloning of the putative chCARDIF. A BLASTP search of the RefSeq
chicken protein database at NCBI using the murine CARDIF protein se-
quence (NCBI NP_659137.1) retrieved a protein sequence of 641 amino
acids with unknown function, designated hypothetical protein
LOC422936 (NP_001012911.1) (6). The corresponding cDNA sequence
(GenBank no. NM_001012893.1) was used to design the oligonucleo-
tides ch-CARDIF-L and ch-CARDIF-R for reverse transcription-PCR
(RT-PCR) from chicken spleen RNA. The PCR fragment was cloned
into pCR4-TOPO and transferred with KpnI and EcoRI to pcDNA6-
V5-His B. The nucleotide sequence of the putative chCARDIF was
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determined from both strands of two independent clones (GenBank
no. HQ845772). The sequence was found to be identical to GenBank
no. NM_001012893.1.
Construction of plasmids encoding untagged orN-terminallyHT7-
tagged chCARDIF and deletion mutants thereof. The chCARDIF open
reading frame (ORF) was amplified by PCR using the oligonucleotides
N-chCARDIF-F and N-chCARDIF-R. A chCARDIF lacking the putative
N-terminal CARD domain was designed using the oligonucleotides N-d-
chCARD-F and N-chCARDIF-R. A deletion mutant devoid of the puta-
tive C-terminal transmembrane domain (TM) was constructed using the
oligonucleotides N-chCARDIF-F and d-chTM-R. A further double dele-
tion construct, lacking the CARD and the TM domains, was generated
with the oligonucleotides N-d-chCARD-F and d-chTM-R. To generate
N-terminally HaloTag 7 (HT7)-tagged proteins, the different chCARDIF
fragments were inserted in pFN21K-HT7-CMV (Promega) between the
AsiSI and PmeI sites. A control plasmid for the expression of the HT7 tag
alone was constructed by ligating a DNA cassette composed of the an-
nealed 5=-phosphorylated oligonucleotides Halo-ctrl-F and Halo-ctrl-R
into the SgfI and PmeI sites of pFN21K-HT7-CMV. To obtain the corre-
sponding untagged constructs, the pFN21K-HT7-CMV-derived con-
structs were digested with the restriction endonucleases NheI and XhoI,
and the overhangs were filled in with the large Klenow fragment of DNA
polymerase I (New England BioLabs) before religation and sequence ver-
ification.
chCARDIF localization study. The plasmid pHcRed1-Mito (Clon-
tech), encoding far-red fluorescent protein HcRed1 fused to the mito-
chondrial targeting sequence of the human cytochrome c oxidase subunit
VII, was used to label mitochondria. DF-1 cells were cotransfected with
pHcRed1-Mito and plasmids encoding N-terminally HT7-tagged
chCARDIF or deletion mutants thereof. The next day, the cells were
treated with the green fluorescent HaloTag R110 direct ligand (Promega)
to stain theHT7-tagged proteins, as described by themanufacturer. Image
acquisition employed a Leica TCS-SL spectral confocal microscope to-
gether with Leica LCS software (Leica Microsystems AG). Images were
analyzed and micrographs prepared using the Imaris 7.2 software pro-
gram (Bitplane AG).
TABLE 1 Oligonucleotides used for plasmid constructions
Name Sequence (5=–3=)
Y-NS1mutAV-Ra TCCTTCTTCTGTGAAAACTCTAAG
Y-NS1mutAV-Fa GCAATCGTGGGAGAAATCTCAC
NS1-Y-La ATTGGATCCACCATGGATCTCAACACTGTGTCAAG
NS1-VY-Ra CATGAATTCTTATCAAACTTCTGACTCAATTGTTC
dNS1-V-Ra CTGAAAGCTTGACACAGTGTTGG
dNS1-V-La GACATACTGATGAGGATGTC
ch-P-IFNb-La TAGCCCGGGCTCCCACTCTGGTTGCATCAG
ch-P-IFNb-Ra TAGAAGCTTAACCTTGGTGGGACTTGTGTTC
ch-P-Mx-La TAGCCCGGGTCGGTGTCACATCCACACGG
ch-P-Mx-Ra TAGAAGCTTCTGCCAGAGTCACACAGCAAG
ch-CARDIF-La ATAGGTACCACCATGGGTTTCGCCGAGGACAAAG
ch-CARDIF-Ra CATGAATTCCTATTTCTGCAATCGTGTGTACAC
N-chCARDIF-Fa TATAGCGATCGCCATGGGTTTCGCCGAGGACAAAG
N-chCARDIF-Ra CCATGTTTAAACCTATTTCTGCAATCGTGTGTACAC
N-d-chCARD-Fa TATAGCGATCGCCATGCAGAACAATGCAGGGCACCTGG
d-chTM-Ra CCATGTTTAAACCTACGGCCCATTGCTGTCCCCTG
Halo-ctrl-Fa CGCCTGATAGCTAACTGAGTTT
Halo-ctrl-Ra AAACTCAGTTAGCTATCAGGCGAT
ch-IRF-3-La ATAAAGCTTGCCACCATGGCAGCGCTGGACAGCG
ch-IRF-3-Ra CATGAATTCAGTCTGTCTGCATGTGGTATTG
ch-MDA5-La ATAAAGCTTGCCACCATGGTACACGTCAGTTTTGTTTTC
chMDA5-BamHI-Ra GATCTCAATAATTCTTTCTCTAAATG
chMDA5-int-La GTCAGAGAGAGCAGTGTATTGG
ch-MDA5-Ra CATGTTTAAACTTAATCTTCATCACTTGAAGGACA
chRLRlgp2-F-HindIIIa TATAAAGCTTATGGAGCTCCACGGGTACCAAC
chRLR_R_Stop_BamHIa GCATGGATCCCTACAGGGACTCGTCCTGAGTG
hRIG-I-La ATAAAGCTTGCCACCATGACCACCGAGCAGCGACGCAG
hRIG-I-Ra TTACTCGAGTCATTTGGACATTTCTGCTGGATC
huMDA5-La ATAGGTACCACCATGTCGAATGGGTATTCCACAG
huMDA5-S-Ra TTACTCGAGCTAATCCTCATCACTAAATAAACAGC
1hp-Lb ggcggggctagctggagaagatgccttccggagaggtgctgctgagcg
1hp-Rb gggtggacgcgtaagaggggaagaaagcttctaaccccgctattcaccaccactaggca
CTRL-sh-Fb gagaggtgctgctgagcgaAGGTAGTGTAATCGCCTTGCAtagtgaagccacagatgta
CTRL-sh-Rb attcaccaccactaggcaCAGGTAGTGTAATCGCCTTGCAtacatctgtggcttcact
chMDA5-sh3-Fb gagaggtgctgctgagcgaGAGCAGAATAGTGCAGAAGAAtagtgaagccacagatgta
chMDA5-sh3-Rb attcaccaccactaggcaTGAGCAGAATAGTGCAGAAGAAtacatctgtggcttcact
chCARDIF-sh3-Fb gagaggtgctgctgagcgaTCAGCTCCTCCAAGTGCTTCAtagtgaagccacagatgta
chCARDIF-sh3-Rb attcaccaccactaggcaCTCAGCTCCTCCAAGTGCTTCAtacatctgtggcttcact
chIRF3-sh3-Fb gagaggtgctgctgagcgcGTCCAAGCTCATCCTGGTGAAtagtgaagccacagatgta
chIRF3-sh3-Rb attcaccaccactaggcaAGTCCAAGCTCATCCTGGTGAAtacatctgtggcttcact
a Oligonucleotides used for PCR-based cloning.
b Oligonucleotides used for the construction of pRFPRNAiC-derived plasmids for the expression of short hairpin RNA (the target sequence is marked in capitals). The 5= base of the
sense strands (underlined in the oligonucleotide sequences) were modified to form mismatches to mimic the endogenous miRNA30.
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Cloning of chMDA5, putative chLGP2, and chIRF3. chMDA5 was
cloned based on the GenBank no. XM_422031.2 sequence. The
N-terminal fragment was amplified with the oligonucleotides ch-
MDA5-L and chMDA5-BamHI-R and was cloned with HindIII and
BamHI into pcDNA6-V5-His B. The C-terminal part was amplified with
chMDA5-int-L and ch-MDA5-R. The plasmid pcDNA6-chMDA5 was
obtained by cloning the BamHI- and PmeI-digested C-terminal fragment
into the BamHI and EcoRV sites. Sequence analysis of three independent
clones revealed a histidine-to-arginine change at position 477 (H477R)
compared to the published chMDA5 (8) andNP_001180567.1 sequences.
To express the CARD domains of chMDA5, a fragment encoding the
N-terminal 642 amino acids was obtained by RT-PCR using the oligonu-
cleotides ch-MDA5-L and chMDA5-BamHI-R and cloned into the
HindIII and BamHI sites of pcDNA6-V5-His B. The putative chLPG2
terminal sequences were identified based on similarities to mammalian
LGP2 sequences. The putative chicken LGP2 (chLGP2) was cloned by
RT-PCR using the oligonucleotides chRLRlgp2-F-HindIII and chRLR-R-
Stop-BamHI. The HindIII- and BamHI-digested PCR fragment was li-
gated into the respective sites of pcDNA6-V5-His B. The nucleotide se-
quence of chLGP2 was determined from two strands of two independent
clones and deposited inGenBank (HQ845773). The chIRF3 gene (14) was
amplified from chicken spleen RNA by RT-PCR using the oligonucleo-
tides ch-IRF-3-L and ch-IRF-3-R and was cloned into the HindIII and
EcoRI sites of pcDNA6-V5-His B. The full-length human RIG-I
(huRIG-I) and MDA5 (huMDA5) were originated from plasmids kindly
provided by Ralf Bartenschlager, Department of Molecular Virology,
University of Heidelberg, Germany (5). All plasmid inserts were se-
quenced.
Expression of shRNA and siRNA transfection. For specific gene
knockdown in chicken cells, pRFPRNAiC-based silencing (ARK-
Genomics, Scotland, United Kingdom) was applied (10). The 22-
nucleotide RNA interference (RNAi) target sequences were designed us-
ing the Genscript RNAi target finder (https://www.genscript.com/ssl-bin
/app/rnai). Hairpins to clone into the microRNA (miRNA) cloning site
were generated by PCR using random and gene-specific oligonucleotides
together with 1hp-L and 1hp-R (Table 1). The control short hairpin RNA
(shRNA) (CTRL-sh) sequence was derived from a random short interfer-
ing RNA (siRNA) designed by Microsynth (Balgach, Switzerland). The
PCR products were cloned with NheI and MluI into pRFPRNAiC.
Double-stranded siRNAs (21-mers with TT overhangs at the 3= ends)
were designed and purchased as annealed duplexes fromMicrosynth (Ta-
ble 2). For silencing, DF-1 or HD-11 cells were transfected with siRNAs at
a 100 nM final concentration using TransIT-TKO (Mirus) according to
the manufacturer’s protocol.
Real-time quantitative RT-PCR. RNA was extracted using TRIzol
(Invitrogen), DNase I (Ambion), and RNase inhibitor (RNasin Plus; Pro-
mega) orwith theNucleospinRNA II kit (Macherey-Nagel) and amplified
with the SuperScript III platinum one-step quantitative RT-PCR system
(Invitrogen) using oligonucleotide primers and probes (Table 2) pur-
chased fromMicrosynth. Primers and probes for chIFN-were published
earlier (37). As an internal standard, the primers Avi18S-F and Avi18S-R
and the probe Avi18S-P, specific for the chicken 18S rRNA, were used
(GenBank no. AF173612.1).
Nucleotide sequence accession number. The nucleotide sequences
of the open reading frames of the putative chCARDIF and chLGP2
have been deposited in GenBank under accession numbers HQ845772
and HQ845773.
RESULTS
Chicken DF-1 and HD-11 cells can be stimulated with dsRNA
and IVT-RNA to produce type I interferon. To characterize the
response of chicken cell lines to stimulation with RNAmimicking
the danger signals associated with viral infections, DF-1 fibroblast
cells and HD-11 macrophage-like cells were stimulated with
dsRNA and 5=-triphosphorylated ssRNA analogues. DF-1 cells re-
sponded to transfected p(I:C) [t-p(I:C)] and to transfected 5=-
triphosphorylated IVT-RNA (t-IVT-RNA) with a strong IFN-
promoter induction, similarly to the case for the human
HEK293T cell line (Fig. 1A and B). Accordingly, bioactive type I
chIFN was detected in the supernatant of DF-1 and HD-11 cells,
with a 10-fold higher response measured in HD-11 cells (Fig. 1C
and D). The transfection of all cell lines with ssRNA of the same
sequence as the IVT-RNA but devoid of 5= triphosphates did not
induce any detectably type I IFN response (Fig. 1A to G).
Chicken cells respond to dephosphorylated IVT-RNA, un-
likeHEK293T cells.As expected fromprevious reports (18), IVT-
RNA from which the 5=-ppp were removed enzymatically lost
their ability to activate the IFN- promoter in human HEK293T
cells (Fig. 1E). Surprisingly, the CIP treatment of IVT-RNA did
not alter the capacity of t-IVT-RNA to induce the chIFN- pro-
moter inDF-1 cells and type I chIFN secretion inHD-11 cells (Fig.
TABLE 2 Sequences of siRNAs used for silencing and of primers and probes used for quantitative real-time RT-PCR
Name Sequencea (5=–3=) Application
CTRL-siRNA AGGUAGUGUAAUCGCCUUG siRNA
chMDA5-siRNA2 AAGAAGGGAUCCAUUUAGA siRNA
chMDA5-siRNA3 AUAUAAUGAUGCUCUGCAA siRNA
chCARDIF-siRNA2 UGCUGCAGGAAGCUUUGAA siRNA
chLGP2-siRNA1 UGGAGAUGAUCUACCGGAA siRNA
Avi18S-F TCCCCTCCCGTTACTTGGAT RT-PCR
Avi18S-R GCGCTCGTCGGCATGTA RT-PCR
Avi18S-P FAM-ACTGTGGTAATTCTAGAGCTA-BHQ1 RT-PCR
chIFN--F CCTCCAACACCTCTTCAACATG RT-PCR
chIFN--R TGGCGTGCGGTCAAT RT-PCR
chIFN--P FAM-TTAGCAGCCCACACACTCCAAAACACTG-TAMRA RT-PCR
chMDA5-F GGACGACCACGATCTCTGTGT RT-PCR
chMDA5-R CACCTGTCTGGTCTGCATGTTATC RT-PCR
chMDA5-P FAM-CAGCTGCTGCACGGCACGCT-BHQ1 RT-PCR
chCARDIF-F CACCCACGAGGTCCATGTG RT-PCR
chCARDIF-R TGCTTCATCTGGGACATCATTG RT-PCR
chCARDIF-P FAM-CATCACCCCAGTGCCCCGCTC-BHQ1 RT-PCR
a FAM, 6-carboxyfluorescein; BHQ1, black hole quencher 1; TAMRA, 6-carboxytetramethylrhodamine.
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1F and G). The response to dephosphorylated t-IVT-RNA was
dependent on the presence of RNA, as the RNase treatment abol-
ished the induction of type I IFN (Fig. 1E toG). These data suggest
that DF-1 and HD-11 cells sense IVT-RNA by intracellular RIG-
I-like receptors independently of the 5=-ppp moieties, as opposed
to human HEK293T cells.
DF-1 cells respond to danger signalsmediated byH5N1AIV.
The infection of DF-1 cells with LPAIV Vac-1/04 (Fig. 1H) and
HPAIV Yamaguchi-7/04 (data not shown) did not activate the
chIFN- promoter regardless of the multiplicity of infection
(MOI). However, a recombinant Vac-1/04 virus lacking the entire
NS1 gene (Vac-NS1) induced a strong upregulation of the
chIFN- promoter in anMOI-dependent manner (Fig. 1H). This
shows that DF-1 cells can sense AIV in the absence of RIG-I. Im-
portantly, wild-type Vac-1/04 counteracts the activation of type I
chIFN by means of the NS1 protein, as expected from previous
reports (27, 45).
Identification, cloning, and sequence analysis of the putative
chicken CARDIF and chicken LGP2. To characterize the RLR sig-
naling pathway involved in the induction of type I chIFN in chicken
cells, we sought to characterize chicken genes coding for potential
CARD-likedomains similar to those found in themammalianRIG-I,
MDA5, and CARDIF proteins. We identified a putative chicken
ortholog (GenBank accession number NP_001012911.1) of the
mammalian CARDIF based on a BLASTP search of the chicken
genome reference protein database at NCBI using the murine
CARDIF amino acid sequence. This protein was previously de-
scribed in a phylogenic tree of known and predicted CARDIF
proteins from various species but not further characterized (55).
Therefore, we cloned and sequenced the open reading frame of the
putative chCARDIF and deposited the nucleotide sequence in
GenBank (accession number HQ845772). Forty percent identity
was found for the N-terminal 95 amino acids that form the char-
acteristic CARDdomain present inmammalianCARDIF proteins
(39). The Conserved Domain Database (CDD) at NCBI (http:
//www.ncbi.nlm.nih.gov/cdd) predicts a CARD domain
(CARD_IPS1 [cd08811]) from amino acids 5 to 88 of the putative
chCARDIF. Apart from the putative N-terminal CARD domain
that is conserved from pufferfish to human, the amino acid se-
quence alignment of CARDIF revealed only limited identity be-
tween the full-length chicken protein and the human and mouse
CARDIF sequences (26.3 and 21.7% identity, respectively). We
FIG 1 Type I interferon responses of chicken cells stimulated with ssRNA and dsRNA analogues. The effect of dsRNA and ssRNA (A to D), of triphosphorylated
ssRNA (E to G), and of AIV (H) on IFN- promoter induction (A, B, E, F, and H) and on type I chIFN bioactivity (C, D, and G) were analyzed in chicken DF-1
fibroblast cells (A, C, F, and H), in chicken macrophage-like HD-11 cells (D and G), and in human HEK293T cells (B and E). The induction of the IFN-
promoter-dependent firefly luciferase was normalized to that of Renilla luciferase and expressed as fold induction compared to that of unstimulated cells. The
type I chIFN in the supernatant was quantifiedwith the bioassay. For the analysis of type I IFN induction by dsRNA and ssRNA (A toD), the cells were stimulated
with 2 g/ml (high dose) and 0.5 g/ml (low dose) of p(I:C) or t-p(I:C), with 1 g/ml (high dose) and 0.25 g/ml (low dose) of t-IVT-RNA, or with synthetic
ssRNA of the same sequence (t-ssRNA). (E to G) The IVT-RNA and ssRNA concentrations were 0.25g/ml for DF-1 andHD-11 cells and 1g/ml forHEK293T
cells. The cells were stimulatedwith t-IVT-RNAorwith t-ssRNA that were previously dephosphorylatedwith calf intestinal phosphatase (CIP) or digestedwith
an RNase cocktail (RNase) or the untreated RNAs (), as indicated. (H) DF-1 cells were transfected with chIFN- promoter reporters prior to infection with
AIV. The data are representative of at least two independent experiments performed in triplicate wells, with the bars representing the mean values and the error
bars showing the standard deviations.
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also identified a closely related putative CARDIF sequence from
the zebra finch (Taeniopygia guttata; GenBank accession number
XP_002188030.1) that shares 49% amino acid identity with the
full-length putative chCARDIF. SMART analysis (http://smart
.embl-heidelberg.de/) and the TMHMMserver v. 2.0 (http://www
.cbs.dtu.dk/services/TMHMM-2.0/) were used to predict TM do-
mains in the putative chicken CARDIF protein sequence. The two
software programs identified a C-terminal TM domain spanning
from amino acids 617 to 636, which is consistent with the mam-
malian CARDIF proteins being mitochondrial transmembrane
proteins. A proline-rich region was found in the central region of
the putative chCARDIF,which is also in agreementwith themam-
malian CARDIF.
We also identified expressed sequence tags (ESTs) of a putative
chicken LPG2 (chLGP2) based on similarities with mammalian
LGP2 terminal sequences. The open reading frame of the putative
chLGP2 was cloned and entirely sequenced. The nucleotide se-
quence was deposited in GenBank under the accession number
HQ845773. The putative chLGP2 gene encodes a protein of 674
amino acids with 53 and 52% identity with human and mouse
LGP2, respectively. Consistently with mammalian LGP2, CDD
analysis revealed that chLGP2 also is devoid of any CARDdomain
and consists of a DEAD-like helicase superfamily domain
(DEXDc [cd00046]; from amino acids 18 to 170), a helicase su-
perfamily C-terminal domain (HELICc [cd00079]; amino acids
344 to 470), and the RIG-I regulatory domain (RIG-I_C-RD
[pfam11648]; amino acids 549 to 666).
The putative chCARDIF is associating with mitochondria.
Confocalmicroscopywas used to analyze the subcellular localization
of the putative chCARDIF. To this end, we expressed N-terminally
HT7-tagged chCARDIF (HT7-chCARDIF), as well as HT7-tagged
chCARDIF devoid of the N-terminal CARD-like domain (HT7-
chCARDIF-CARD), the C-terminal transmembrane domain
(HT7-chCARDIF-TM), or both (HT7-chCARDIF-CARD-
TM). Wild-type and mutant putative chCARDIF proteins were
expressed at similar levels, as determined byWestern blot analysis
using a specific polyclonal anti-HT7 antiserum (data not shown).
The plasmid pHcRed1-Mito, encoding far-red fluorescent protein
HcRed1 fused to amitochondrial targeting sequence, was cotrans-
fected with the sequences described above for visualization of the
mitochondria. The green fluorescent HT7-tagged chCARDIF was
clearly seen to be associating with the red fluorescent mitochon-
dria (Fig. 2). This was visualized by the overlapping of the two
fluorescences (top row). The green chCARDIF is seen to be asso-
FIG 2 Putative chCARDIF localizes to the mitochondria. DF-1 cells were cotransfected with plasmid pHcRed1-Mito together with plasmids expressing
N-terminally HT7-tagged chCARDIF (chCARDIF), HT7-tagged chCARDIF with deleted N-terminal CARD domain (chCARDIF-CARD), HT7-tagged
chCARDIF with deleted C-terminal TM (chCARDIF-TM), or HT7-tagged chCARDIF with both CARD and TMdeleted (chCARDIF-CARD-TM). The red
fluorescence of the HcRed1 protein and the green fluorescence of the HaloTag R110 direct ligand covalently bound to HT7-tagged protein were analyzed by
confocal microscopy with the Imaris 7.2 software program. The top row showsmicrographs obtained by combining a series of sections taken for the selected cell
to create a 3D image; this is shown as the whole cell (depicted using the Surface analysismodule of Imaris 7.2), overlapping green and red fluorescence in this cell,
green fluorescence alone, and red fluorescence alone (reading from left to right). The secondmicrograph for each construct shows a small box which depicts the
region of the zoomed image shown in the middle and bottom rows. This middle row shows a maximum intensity projection (MIP) display of the image in 3D,
while the bottom row shows a shadow projection display of the image in 3D. The MIP and shadow projection displays have been turned to give a clear
appreciation of the positioning of the two colors: a few degrees for the chCARDIF and chCARDIF-CARD images, 180° for the chCARDIF-TM image, and 90°
for the chCARDIF-CARD-TM image. The scale bars represent 5 to 10 m in the top row and 1 to 2 m in the middle and bottom rows, as indicated.
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ciated with the red mitochondria in the three-dimensional (3D)
images (middle and bottom rows). The rotation of the image con-
firmed this interpretation (data not shown). The deletion of the
CARDdomain from chCARDIF gave images exemplified by those
shown in the second panel of Fig. 2 (chCARDIF-CARD). These
demonstrated that in the absence of the CARD domain, the green
chCARDIF still could associate with the redmitochondria. Zoom-
ing in on the boxed area marked on the second micrograph in the
top row again showed a close association in the 3D images ob-
tained. Indeed, one could not distinguish the degree of association
between CARD-deleted chCARDIF and mitochondria from that
observed with the intact chCARDIF, suggesting that chCARDIF
does not require the intact CARD domain to associate with
mitochondria. In contrast to the deletion of the CARD domain,
the truncation of the C-terminal TM domain of the putative ch-
CARDIF did disrupt mitochondrial association. This can be seen
most clearly with the zoomed MIP and shadow projection 3D
images (Fig. 2, chCARDIF-TM, middle and bottom rows). The
green chCARDIF is more dispersed, appearing to be cytosolic
rather than organelle associated. Some of the green fluorescence
appears close to the redmitochondrial label, but this is likely to be
juxtapositioning by chance due to the dispersed cytosolic-like lo-
calization of chCARDIF-TM. Certainly there is no intense
organelle-like staining of the green CARDIF together with the red
mitochondria, as was clearly observed with the intact chCARDIF
or CARD-deleted chCARDIF (Fig. 2, chCARDIF and chCARDIF-
CARD). This was confirmed using the double deletion of CARD
and TM (Fig. 2, chCARDIF-CARD-TM), which again showed
a more cytosolic pattern of green fluorescence for chCARDIF.
These results indicate a critical requirement of the TM domain in
chCARDIF for appropriate mitochondrial association.
The N terminus of chMDA5 and of the putative chCARDIF
are involved in type I IFN induction inDF-1 cells.The cytomeg-
alovirus (CMV)-promoter-driven expression of the N-terminal
642 amino acids of the chMDA5 encompassing the CARD do-
mains (N-chMDA5), of the putative chCARDIF, and of chIRF3
elicited a potent induction of the chIFN- and chMxpromoters in
transfected DF-1 cells (Fig. 3A and B). Similarly, the transfection
of the CEC-32 Mx reporter cells with plasmid constructs for the
expression of N-chMDA5, the putative chCARDIF, and chIRF3
resulted in the induction ofMx-driven luciferase expression (data
not shown). The expression of the putative chCARDIF lacking
the CARD domain (chCARDIF-CARD) failed to induce the
chIFN- promoter (Fig. 3C). Also, the truncation of the predicted
FIG 3 chCARDIF is an activator of type I IFN. The impact of the exogenous expression of the putative chCARDIF on the chIFN- (A and C) and chMx (B)
promoters in DF-1 cells, on the huIFN- promoter in HEK293T cells (D), and on the establishment of an antiviral state in DF-1 cells (E) is shown. Promoter
reporter assays were performed by the cotransfection of the indicated reporter plasmids together with decreasing amounts of plasmids expressing theN-terminal
CARD domains of chMDA5 (N-chMDA5), putative chCARDIF, chIRF3, or empty plasmid as a vector control (A and B). (C) Using the same approach,
chCARDIF was compared to mutants lacking the putative CARD domain (chCARDIF-CARD), the predicted transmembrane domain (chCARDIF-TM), or
the two domains (chCARDIF-CARD-TM). (D) HEK293T cells were cotransfected with plasmids to conduct the human IFN- reporter assay and with
chCARDIF or chIRF3. The expression of human RIG-I (huRIG-I) served as a positive control. (A to D) The firefly and Renilla luciferase activities were
determined after overnight incubation and expressed relative to vector control-transfected cultures. (E) DF-1 cells were transfected with chCARDIF or
N-chMDA5 (both 1 g/ml) and 18 h later were infected with a luciferase-expressing VSV replicon [VSVG(Luc); MOI, 10] for 8 h. Data were obtained from
quadruplicate transfections and are representative of at least two independent experiments.
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C-terminal TM domain (chCARDIF-TM) resulted in approxi-
mately 10-fold reduced activity. As expected, the putative
chCARDIF lacking the CARD and the TM domains did not acti-
vate the chIFN- induction pathway (Fig. 3C). Interestingly, the
putative chCARDIF and chIRF3 activated the human IFN- pro-
moter inHEK293T cells with levels comparable to those of human
RIG-I (Fig. 3D). To elaborate on the functional relevance of the
type I chIFN inductions measured above, we showed that the
plasmid-driven expression of N-chMDA5 and of the putative ch-
CARDIF was sufficient to inhibit the replication of a recombinant
vesicular stomatitis virus replicon, VSV*G(Luc), expressing fire-
fly luciferase (Fig. 3E). Taken together, these data strongly suggest
that the protein identified as putative chCARDIF is part of the type
I chIFN induction cascade, in analogy to the mammalian CAR-
DIF.
The putative chCARDIF mediates type I chIFN induction
downstreamof chMDA5andupstreamof chIRF3.Themamma-
lian CARDIF functions downstream of RIG-I andMDA5 and up-
stream of IRF3 in the type I IFN induction cascade (46). To verify
whether this also applies to the putative chCARDIF in chicken
cells, the activation of the chIFN- promoter in DF-1 cells was
analyzed after the silencing of chMDA5, chCARDIF, and chIRF3
gene expression using the pRFPRNAiC-driven synthesis of spe-
cific shRNA (Fig. 4A). The silencing of chMDA5 significantly re-
duced the activation of the chIFN- promoter mediated by the
overexpression of N-chMDA5 but not by the overexpression of
the putative chCARDIF or chIRF3. The shRNA targeting the pu-
tative chCARDIF substantially decreased chIFN- promoter in-
duction in cells stimulated with the expression of N-chMDA5 and
the putative chCARDIF itself but had only a minor effect in cells
stimulated with chIRF3. Finally, the shRNA targeting of chIRF3
abolished chIFN- activation with all three stimuli. A control
shRNA composed of a random, nontargeting sequence did not
have any effect on the promoter activity induced by N-chMDA5,
chCARDIF, and chIRF3 overexpression. Taken together, these
data demonstrate that the putative chCARDIF represents the
chicken analog of the mammalian CARDIF, functioning down-
stream of the RLR and upstream of chIRF3.
chMDA5, chCARDIF, and chIRF3 are required for virus-
mediated type I IFN induction in DF-1 cells. Gene silencing
also was applied to determine the requirement of chMDA5,
chCARDIF, and chIRF3 in response to danger signalsmediated by
virus infections. To this end, dsRNA, triphosphorylated ssRNA, a
FIG 4 chMDA5, chCARDIF, and chIRF3 are required to sense viral danger
signals in chicken cells. (A to D) The influence of the shRNA-mediated silenc-
ing of chMDA5, chCARDIF, and chIRF3 on the induction of the chIFN-
promoter reporter was analyzed in DF-1 cells. (E and F) The effects of siRNA-
based silencing of chMDA5 and chCARDIF on AIV-induced chIFN-mRNA
induction were examined in DF-1 and HD-11 cells. (A to D) The cells were
cotransfected with pRFPRNAiC-derived plasmids (at 1 g/ml) for shRNA
transcription as indicated and with reporter plasmids for chIFN- promoter
activity. Note that the shRNA directed against chMDA5 is targeted to the
5=-terminal region of themRNA. The cells were stimulatedwith the expression
of N-chMDA5 (100 ng/ml), chCARDIF (200 ng/ml), or chIRF3 (200 ng/ml)
using pcDNA6-derived constructs (A); with t-p(I:C) (1.5 g/ml) (B); with
t-IVT-RNA (0.5 g/ml) or with VSV*MQG infection (MOI, 10) (C); and
withVac-NS1 infection (MOI, 10) (D). After 18 h, a dual-luciferase assaywas
performed. Results were obtained from four (A and C) or six (B andD) exper-
iments. The data were expressed relative to the luciferase activity in DF-1 cells
transfected with nontargeting pRFPRNAiC-CTRL-sh set to 100%. Error bars
indicate standard deviations. In cells transfected with pRFPRNAiC CTRL-sh
plasmid, the fold induction above that of unstimulated cells with t-p(I:C),
t-IVT RNA, VSV replicon, and Vac-NS1 were 57 (5.3 SD), 69.9 (23.1),
9.5 (3.4), and 76 (15.1), respectively. (E and F) DF-1 andHD-11 cells were
transfected with specific siRNA targeting chMDA5 or chCARDIF or with ran-
dom control siRNA (CTRL-siRNA) as indicated. The cells then were infected
with Vac-NS1 or mock infected. Relative chIFN- mRNA levels were as-
sessed by quantitative real-time RT-PCR analysis 6 h after infection. Average
mRNA levels derived from infected cells treated with CTRL-siRNAwere set to
100%. Experimentswere performed in quadruplicate. Error bars indicate stan-
dard deviations. The differences between the effects observed from targeting
siRNA and CTRL-siRNA were statistically significant (t test).
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VSV replicon, and an AIV lacking NS1 were used as triggers. As
expected, chMDA5, chCARDIF, and chIRF3 all were required for
chIFN- promoter induction by t-p(I:C) (Fig. 4B) and t-IVT-
RNA, mimicked the viral PAMP (Fig. 4C). Accordingly, the si-
lencing of chMDA5, chCARDIF, and chIRF3 also prevented the
chIFN- promoter induction by VSV*MQG (Fig. 4C) and by
AIV Vac-NS1 (Fig. 4D). To extend this study to chicken macro-
phages, we evaluated the effects of siRNA-based chMDA5 and
chCARDIF silencing on AIV-induced chIFN-mRNA induction
in HD-11 cells. As expected from the previous experiments, the
siRNA targeting of chMDA5 and chCARDIF significantly reduced
chIFN-mRNA expression induced by AIV Vac-NS1 infection
in DF-1 and HD-11 cells (Fig. 4E and F).
The effectiveness of shRNA- and siRNA-mediated silencing of
gene expression was analyzed in DF-1 cells by Western blotting and
quantitative RT-PCR (Fig. 5). With shRNA, tagged chMDA5 and
chCARDIF proteins were efficiently downregulated (Fig. 5A
and B). The siRNA-mediated silencing of chMDA5 reduced the
protein and mRNA levels by approximately 60% (Fig. 5C and D).
The mRNA level of chCARDIF was reduced to a similar extent by
siRNA treatment (Fig. 5E). Collectively, the gene-silencing exper-
iments demonstrate the requirement of chMDA5, chCARDIF,
and chIRF3 for sensing RNA virus infections in chicken cells.
chLGP2 is required for type I chIFN induction in DF-1 and
HD-11 cells. The LGP2 helicase regulates RIG-I- and MDA5-
mediated responses in mammals (40, 42). The downregulation of
the putative chLGP2 in DF-1 and HD-11 cells reduced type I
chIFN secretion (Fig. 6A andB), indicating that chLGP2 functions
are required for chRLR signaling. On average, the supernatants of
Vac-NS1-infected DF-1 and HD-11 cells contained 7.7 U/ml
(1.6 standard deviations [SD]) and 8.2 U/ml (0.9 SD) of type
I chIFN 18 and 6 h after infection, respectively. Moreover, the
gene-silencing experiments altogether demonstrate the require-
ment of chMDA5, putative chLGP2, chCARDIF, and chIRF3 for
AIV-mediated type I IFN induction in chicken cells. The siRNA-
mediated silencing of tagged chLGP2 protein is demonstrated in
Fig. 6C. In mammalian cells, LGP2 negatively regulates RLR-
mediated signaling when it is overexpressed (40). Therefore, we
tested whether this also applies to the putative chLGP2. As ex-
pected, the expression of the putative chLGP2 interfered with the
FIG 5 Validation of shRNA- or siRNA-mediated silencing of chMDA5 and chCARDIF gene expression. Specific shRNA-mediated (A and B) and siRNA-
mediated (C to E) knockdowns of target gene expression were investigated in chicken DF-1 cells. (A and B) The cells were cotransfected with control vector or
with plasmids expressing either C-terminal V5-tagged chMDA5 (chMDA5-V5) (A) or N-terminal HT7-tagged chCARDIF (HT7-chCARDIF) (B) together with
the indicated pRFPRNAiC-derived plasmids for the transcription of specific or random control shRNAs (all plasmids were at 0.5 g/ml). After 2 days, the
expression levels of tagged chMDA5 and chCARDIF were quantified byWestern blotting and immunodetection using anti-V5 antibody or anti-HT7 polyclonal
serum. For normalization purposes, the -actin content was determined with anti--actin MAb. The relative signal intensity measured in the presence of
gene-specific shRNA is indicated as a percentage of the signal measured with CTRL-shRNA. (C) Cells were transfected with chMDA5-V5 or the vector control
(at 0.5 g/ml) for 6 h, followed by siRNA transfections as indicated. Two days later, the relative protein expression level of chMDA5-V5 was quantified by
Western blot analysis as described for panels A and B. (D and E) Cells were transfected with specific siRNA targeting chMDA5 or chCARDIF or with random
control siRNA (CTRL-siRNA) as indicated. Two days after transfection, the endogenous chMDA5 (D) or chCARDIF (E) mRNA levels were assessed by
quantitative real-time RT-PCR and normalized to the 18S RNA content. The average normalizedmRNA levels measured in cells treated with CTRL-siRNAwere
set to 100%. Transfections were performed in quadruplicate. Error bars indicate standard deviations. The differences between the effects observed with siRNA
and CTRL-siRNA were statistically significant (t test).
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Vac-NS1-driven activation of the chicken RLR pathway (Fig.
6D), indicating that the gene identified as putative chLGP2 indeed
functions similarly to the mammalian LGP2.
H5N1 AIV counteracts the chicken RLR signaling pathway
bymeans of the NS1 protein. Recently, an alanine-to-valine mu-
tation at position 149 (A149V) of the NS1 gene of the HPAIV
A/goose/Guangdong/1/96 (H5N1) was reported to abolish the
counteraction of AIV-mediated type I IFN induction in chicken
fibroblasts (27). The mutant virus was attenuated in chicken. We
introduced this mutation into the NS1 gene from the HPAIV
Yamaguchi-7/04 and the LPAIV Vac-1/04 at positions 144 and
149, respectively, corresponding to position 149 described above.
The expression of the parent NS1 proteins of the two viruses but
not of the respective mutant proteins significantly impaired the
t-p(I:C)-mediated activation of the chIFN- promoter in DF-1
cells independently of the V5 tag (Fig. 7A). Vac-NS1-mediated
chIFN- promoter activation also was impaired by the NS1 pro-
tein of the Yamaguchi-7/04 virus but was only partially blocked by
the A144V mutant (Fig. 7B). The expression of the native NS1
as opposed to the NS1-A144V mutant also prevented the
N-chMDA5-mediated induction of the chIFN- promoter in
DF-1 cells (Fig. 7C). The IRF3-mediated chIFN- promoter in-
duction also was partially reduced by NS1 but not by NS1-A144V.
With the tagged proteins, comparable levels of protein expression
were demonstrated (Fig. 7D). In HEK293T cells, however, both
the parent and the mutant NS1 proteins suppressed the huRIG-I-
and huMDA5-mediated activation of the human IFN- promoter
(Fig. 7E). In summary, these data show that NS1 of H5N1 AIV
inhibits RLR-mediated IFN- induction in chicken and human
cells.
DISCUSSION
In the present study, we characterized the chicken RLR pathway
by defining the role of chMDA5, chLGP2, chCARDIF, and chIRF3
in the recognition of viral PAMP, particularly that of AIV. We
identified the chCARDIF and chLGP2 coding sequences and dem-
onstrated the functions of their products in chMDA5-mediated
signaling and type I IFN induction. The expression of chLGP2
interferes with chMDA5-specific signaling. Finally, we showed
that the MDA5-mediated signaling was inhibited by NS1 of an
H5N1 AIV but not of a mutant NS1 (A144V).
Our results indicate that human and chicken RLR pathways
respond in a fashion similar to that of the stimulationwith dsRNA
but differ in comparisons of 5=-pppRNA to dephosphorylated
RNA. Unlike the human cells, the two chicken cells respond to
both the 5=-pppRNA and the dephosphorylated RNA, indicating
that chicken generally lack the capacity to specifically sense only
5=-ppp RNA structures, as shown for RIG-I in mammalian cells.
As IVT-RNA is known to contain dsRNA structures (43, 44), the
type I chIFN response observed in t-IVT-RNA-stimulated chicken
cells might be due to dsRNA structures. Our data employing
MDA5 gene knockdown performed in chicken DF-1 and HD-11
cells indicate that chMDA5 represents the principle intracellular
PRR mediating AIV and intracellular dsRNA recognition. Con-
sidering that in mammals RIG-I acts as the main cytosolic PRR
involved in sensing influenza virus infections (24) and that chick-
ens lack RIG-I (2, 62), this indicates that the chMDA5 can func-
tionally compensate for the absence of RIG-I in the chicken ge-
nome. Furthermore, the potent activation of the chIFN-
promoter by the infection of DF-1 cells with a recombinant H5N1
FIG 6 chLGP2 is a functional element of the chIFN- activation pathway in DF-1 and HD-11 cells. (A and B) The effects of siRNA-based silencing of chMDA5,
chCARDIF, and chLGP2 on AIV-induced chicken type I IFN secretion were analyzed in DF-1 and HD-11 cells.(C) The siRNA-mediated silencing of chLGP2
gene expressionwas analyzed. (D) The effect of chLGP2 overexpression on theVac-NS1-mediated induction of the chIFN- promoter was determined inDF-1
cells. For silencing,DF-1 (A) andHD-11 cells (B)were transfectedwith specific siRNA targeting chMDA5, chCARDIF, or chLGP2 orwith randomcontrol siRNA
(CTRL-siRNA) as indicated. At 18 (A) or 6 h (B) after Vac-NS1 infection, type I chIFN was quantified using the CEC32-based bioassay. The bioactivity was
expressed relative to the mean values measured from infected and CTRL-siRNA-transfected cells set to 100%. Experiments were performed in quadruplicate.
Error bars indicate standard deviations. The differences between the effects observed from targeting siRNA andCTRL-siRNAwere statistically significant (t test).
To demonstrate the downregulation of chLGP2 by siRNA,DF-1 cells were transfected with pcDNA6-chLGP2-V5 (at 0.5g/ml) or empty vector (vector control)
(at 0.5 g/ml) for 6 h, followed by siRNA transfections as indicated. Two days later, protein expression levels were quantified by Western blotting and
immunodetection using the anti-V5 antibody. (C) The-actin contentwas determinedwith the anti--actinMAb. To assess the effect of chLGP2 overexpression
on IFN- promoter activation, DF-1 cells were cotransfected with constant amounts of reporter plasmids and with pcDNA6-chLGP2 (at 0.5 g/ml) or empty
vector (vector control). (D) After 24 h, the cells were stimulatedwith Vac-NS1 (MOI, 5) or left untreated for another 24 h before performing the dual-luciferase
assay. Experiments were performed in quadruplicate. Data are expressed as percentages of the levels obtained with the corresponding nonstimulated cells. The
normalized luciferase levels obtained with the parent vector DNA were set to 100%.
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AIV lacking theNS1 gene does not support the hypothesis that the
lack of RIG-I represents a reason for the increased susceptibility of
chickens to AIV compared to the susceptibility of ducks that have
the RIG-I gene. Nevertheless, resolving this question would re-
quire in vivo investigations, for instance, employing transgenic
chicken expressing duck RIG-I.
In the present study, we also identified the chCARDIF that is
associated with mitochondria like its mammalian counterpart.
The overexpression of chCARDIF and chIRF3 triggered IFN type
I responses in chicken as well as in mammalian cells, pointing to
the functional conservation of these molecules during evolution.
This was surprising, given the low degree of amino acid identity of
the two chicken genes with their mammalian counterparts. As
expected, gene-silencing experiments revealed that chCARDIF
acts downstream of chMDA5 and upstream of chIRF3. As with
mammalian CARDIF, the association with mitochondria and the
activation of the IFN- promoter were found to be dependent on
the predicted C-terminal TM domain, whereas the putative
N-terminal CARD domain was found to be indispensable for
downstream signaling. Surprisingly, the TM-deficient chCARDIF
retained approximately 10% of the activity of the full-length
chCARDIF, whichmay be explained by the residual binding of the
FIG 7 H5N1 AIV NS1 interferes with chIFN type I induction. The effect of the AIV NS1 protein on the chIFN- promoter (A to C) was analyzed in DF-1 cells
stimulated with t-p(I:C) (A), with Vac-NS1 (B), or with the expression of N-chMDA5 or chIRF3 (C). (E) In comparison, the effect of the AIV NS1 protein on
the huIFN- promoter was characterized in HEK293T cells stimulated with huRIG-I or huMDA5 expression. (A) The cells were cotransfected with constant
amounts of chIFN- reporter plasmids and with pcDNA6 expressing V5-tagged or untagged parent or mutant NS1 from Yamaguchi-7/04 or Vac-1/04 or with
the empty vector (all expression plasmids were at 0.5g/ml). (B) The cells were cotransfected with the chIFN- reporter plasmids and with pcDNA6 expressing
NS1 or NS1-A144V of Yamaguchi-7/04, or with the empty vector, at 50 ng/ml and 0.5 g/ml as indicated. After 24 h, the cells were stimulated with 2 g/ml
t-p(I:C) (A) or with Vac-NS1 virus at an MOI of 10 (B). (C) DF-1 cells were cotransfected with the chIFN- reporter plasmids and with pcDNA6 constructs
expressing N-chMDA5 (50 ng/ml) or chIRF3 (0.5 g/ml) as indicated, pcDNA6 plasmid expressing NS1 or NS1-A144V, or with the empty vector (all NS1
expression plasmids and the vector control were at 0.5g/ml). Dual-luciferase assays were performed after 18 h. Stimulations were performed in quadruplicate.
The levels obtained with parent vector DNA were set to 100%. (D) The expression of the V5-tagged wild-type and mutant Yamaguchi-7/04 NS1 proteins was
analyzed byWestern blotting using the anti-V5MAb.The-actin contentwas determinedwith the anti--actinMAb. (E)HEK293T cells were cotransfectedwith
huIFN- reporter plasmids togetherwith the empty pcDNA6vector or pcDNA6 expressing huRIG-I or huMDA5 (as stimuli) andwith pcDNA6 expressing intact
or mutant NS1 of Yamaguchi-7/04 and Vac-1/04. The empty pcDNA6 vector served as a control (vector control). Dual-luciferase assays with quadruplicate
transfections were performed after 24 h. The relative huIFN- promoter activity was expressed as the percentage of activity obtained with empty pcDNA6.
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truncated protein to the mitochondria, as observed by micros-
copy. Finally, gene-silencing experiments in chicken cells demon-
strate that chCARDIF is required for AIV-induced type I IFN re-
sponses. Similarly, we also show that the chIRF3 transcription
factor is required for chRLR-mediated type I IFN responses, as
expected frommammalian RLR pathways (21). Consistently with
MDA5 inmammalian systems (1, 8), the overexpression of a poly-
peptide containing the twin CARD domains of chMDA5 (N-
chMDA5) activated the chIFN- promoter. LGP2 knockdown ex-
periments in chicken cells demonstrate that chLGP2 is essential to
mediate RLR-specific antiviral responses, as described for human
LGP2 (42, 54), but again, similarly to human (40), chLGP2 over-
expression negatively interfered with AIV-induced innate im-
mune signaling in chicken cells.
In mammals, one of the multiple reported functions of the
influenza ANS1 protein is to antagonize the RIG-I-specific induc-
tion of type I IFNs (12, 15, 32, 35). In analogy with this, we show
that in the chicken system NS1 interferes with the chMDA5-
mediated pathway. The NS1 deletion mutant but not the wild-
type AIV activated the type I IFN pathway, and plasmid-expressed
NS1 suppressed chMDA5-mediated chIFN- promoter activa-
tion. The finding that the expression of NS1 also moderately de-
creased chIRF3-induced chIFN- promoter responsesmay reflect
other functions exerted by the multifunctional NS1 protein, such
as the general suppression of host gene expression.
In conclusion, we demonstrate that the intracellular chMDA5
pathway represents a key anti-AIV innate immune recognition
pathway in chicken cells. Chicken andmammalian RLR pathways
share the common components MDA5, LGP2, CARDIF, and
IRF3, but unlike the case in mammals, chMDA5 possesses the
capacity to sense AIV, apparently in a 5=-ppp-independent man-
ner. Whether the failure of chickens to specifically sense viral 5=-
ppp PAMPs helps to explain the increased susceptibility of chick-
ens to AIV compared to that of ducks remains to be investigated.
It also could be speculated that such species-dependent differ-
ences in innate immune recognition has an effect on virus evolu-
tion in different animals.
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